Hardide plc

DB:9V0 Stock Report

Market Cap: €4.1m

Hardide Valuation

Is 9V0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 9V0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 9V0 (€0.02) is trading below our estimate of fair value (€0.2)

Significantly Below Fair Value: 9V0 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 9V0?

Key metric: As 9V0 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 9V0. This is calculated by dividing 9V0's market cap by their current revenue.
What is 9V0's PS Ratio?
PS Ratio0.7x
SalesUK£4.73m
Market CapUK£3.41m

Price to Sales Ratio vs Peers

How does 9V0's PS Ratio compare to its peers?

The above table shows the PS ratio for 9V0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
BIG1 Bio-Gate
0.8x16.3%€6.3m
BNN BRAIN Biotech
1.2x8.5%€68.8m
2HRA H&R GmbH KGaA
0.1x2.7%€127.3m
NTG Nabaltec
0.6x5.1%€123.6m
9V0 Hardide
0.7x13.8%€3.4m

Price-To-Sales vs Peers: 9V0 is expensive based on its Price-To-Sales Ratio (0.7x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does 9V0's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x2.7%US$132.33m
NSAK OTI Greentech
0.03xn/aUS$594.62k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
9V0 0.7xIndustry Avg. 1.0xNo. of Companies4PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 9V0 is good value based on its Price-To-Sales Ratio (0.7x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 9V0's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9V0 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio5.2x

Price-To-Sales vs Fair Ratio: 9V0 is good value based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (5.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Tokuyama

JP¥196.7b

Produces and sells various chemical products in Japan.

TBT

JP¥16.60

7D

5.7%

1Y

14.5%

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

HGR

UK£0.76

7D

1.5%

1Y

-28.3%

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.55

7D

-4.4%

1Y

-19.9%